Ginkgo Bioworks Holdings Inc
DNAHealthcare·Biotechnology·USA·Small·NYSE·Nov 13 • 7:14 AM ET
10.33+0.10 (0.98%)
2026-11-13 13:15 CET
Market cap
$684.44M
Revenue, TTM
100.74 USD m
Net income, TTM
-275.54 USD m
Free cash flow, TTM
-173.54 USD m
EPS diluted, TTM
-4.63
Price
DNA against its 20, 50 and 200-day averagesPatternshover a marker to name it
43.3% under the 52-week high of 18.22 on 6 Oct 2026. 52-week low 5.37 on 30 Mar 2026. Last 15 sessions, 50.5% high to low
Volume 0.01× normal · the line is the 50-bar volume average
Setup. RS line 40
CANSLIM 3 of 6 — fails: EPS Growth This Year: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%
VCP 5 of 6 — fails: 52-Week High/Low: 0-10% below High
Minervini 2 of 4 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 1 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 3 of 5 — fails: Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 1 of 4 — fails: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 1 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 3 of 4 — fails: Performance: Year +50%
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 2 of 3 — fails: Performance: Year +100%
Profile
DNA52-week range, 39% of the way up
5.3718.22
Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.
| Index | RUT |
|---|---|
| Employees | 485 |
| IPO | Apr 19, 2021 |
| Beta | 1.74 |
| ATR, 14d | 1.37 |
| Rel volume | 0.01 |
| Short float | 19.32% |
| Insider own | 22.36% |
| Inst own | 61.12% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $684.44M |
| Enterprise Value | 794.42M |
| Income | -275.54M |
| Sales | 100.74M |
| Book / share | 6.38 |
| Cash / share | 4.33 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 485 |
| IPO | Apr 19, 2021 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 6.79 |
| Price / book | 1.62 |
| Price / cash | 2.38 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 7.89 |
| Quick Ratio | 4.72 |
| Current Ratio | 4.72 |
| Debt / equity | 1.01 |
| Long-term debt / equity | 1.01 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -4.63 |
|---|---|
| Earnings next year | -4.03 |
| Earnings next quarter | -1.04 |
| Earnings this year | 22.78% |
| Earnings next year | 7.58% |
| Earnings growth, 5 years | 16.87% |
| Past earnings growth | 51.73% -7.49% |
| Past sales growth | -29.11% 17.29% |
| Earnings vs last year | 25.63% |
| Sales vs last year | -44.22% |
| Earnings vs last quarter | 55.86% |
| Sales vs last quarter | -28.65% |
| Earnings | Nov 05 AMC |
| Surprise | 5.59% 28.89% |
Ownership
| Insiders own | 22.36% |
|---|---|
| Insider trades | -0.92% |
| Institutions own | 61.12% |
| Institution trades | 8.45% |
| Return on assets | -23.91% |
| Return on equity | -53.57% |
| Return on capital | -34.89% |
| Gross Margin | 40.40% |
| Operating margin | -242.27% |
| Profit Margin | -273.52% |
| 20-day average | -4.75% |
| 50-day average | 0.26% |
| 200-day average | 19.51% |
Technical
| Shares out | 53.62M |
|---|---|
| Shares floating | 49.11M |
| Short / float | 19.32% |
| Short ratio | 3.95 |
| Short interest | 9.49M |
| 52-week high | 18.22 -43.3% |
| 52-week low | 5.37 +92.4% |
| Volatility | 17.01% 12.98% |
| Average range | 1.37 |
| Strength index | 47.60 |
| Market sensitivity | 1.74 |
| Relative volume | 0.01 |
| Avg Volume | 2.40M |
| Volume | 1,611 |
Performance
| Perf Week | -8.50% |
|---|---|
| Perf Month | -12.16% |
| Perf Quarter | 49.28% |
| Perf Half Y | 33.98% |
| Perf YTD | 24.31% |
| Perf Year | 29.12% |
| Perf 3Y | -79.82% |
| Perf 5Y | -98.00% |
| Perf 10Y | - |
| Recommendation | 4.33 |
| Target Price | 8.00 |
| Prev Close | 10.23 |
| Price | 10.33 |
| Change % | 0.98% |
Analyst ratings
latest 10 of 19| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Aug 07, 2026 | Downgrade | TD Cowen | Buy → Hold | $9 | -12.9% |
| May 15, 2024 | Downgrade | BTIG Research | Neutral → Sell | ||
| May 10, 2024 | Downgrade | William Blair | Mkt Perform → Underperform | ||
| Nov 14, 2023 | Downgrade | Raymond James | Outperform → Mkt Perform | $3.50 → $2.50 | -75.8% |
| Nov 09, 2023 | Downgrade | BTIG Research | Buy → Neutral | ||
| Jun 02, 2023 | Downgrade | Goldman | Neutral → Sell | $3 → $1.25 | -87.9% |
| May 11, 2023 | Downgrade | William Blair | Outperform → Mkt Perform | ||
| Nov 29, 2022 | Initiated | Berenberg | Buy | $6 | -41.9% |
| Oct 04, 2022 | Initiated | Morgan Stanley | Equal-Weight | $5 | -51.6% |
| May 18, 2022 | Downgrade | BofA Securities | Neutral → Underperform | $3 | -71.0% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| ABSI | Absci Corp | 1.63B |
| TWST | Twist Bioscience Corp | 7.57B |
| RXRX | Recursion Pharmaceuticals Inc | 2.11B |
| ABCL | AbCellera Biologics Inc | 3.85B |
| GENB | Generate Biomedicines Inc | 1.61B |
| CDXS | Codexis Inc | 123.32M |
| MRVI | Maravai LifeSciences Holdings Inc | 1.88B |
| NAUT | Nautilus Biotechnology Inc | 304.44M |
| SEER | Seer Inc | 88.75M |
| DYAI | Dyadic International Inc, DE | 14.03M |
Insider trading
latest 14 of 55| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Coen Steven P. | See remarks | Oct 19 '26 | Sale | 10.14 | 766 | 7,770 | 50,168 | Oct 21 04:07 PM |
| Canton Barry | 10% Owner | Oct 19 '26 | Sale | 10.14 | 22,369 | 226,889 | 453,951 | Oct 21 04:06 PM |
| Canton Barry | 10% Owner | Oct 19 '26 | Sale | 10.14 | 18,803 | 190,719 | 356,329 | Oct 21 04:06 PM |
| Shetty Reshma P. | See remarks | Oct 19 '26 | Sale | 10.14 | 22,369 | 226,889 | 453,951 | Oct 21 04:06 PM |
| Shetty Reshma P. | See remarks | Oct 19 '26 | Sale | 10.14 | 18,803 | 190,719 | 356,329 | Oct 21 04:06 PM |
| Kelly Jason R | See remarks | Oct 19 '26 | Sale | 10.14 | 45,682 | 463,353 | 129,065 | Oct 21 04:05 PM |
| Coen Steven P. | Officer | Oct 19 '26 | Proposed Sale | 10.14 | 766 | 7,769 | Oct 19 03:58 PM | |
| Canton Barry | Officer | Oct 19 '26 | Proposed Sale | 10.14 | 18,803 | 190,711 | Oct 19 03:47 PM | |
| Che Austin | Officer | Oct 19 '26 | Proposed Sale | 10.14 | 16,058 | 162,870 | Oct 19 03:45 PM | |
| Shetty Reshma P. | Officer | Oct 19 '26 | Proposed Sale | 10.14 | 22,369 | 226,880 | Oct 19 03:42 PM | |
| Kelly Jason R | Officer | Oct 19 '26 | Proposed Sale | 10.14 | 45,682 | 463,334 | Oct 19 03:38 PM | |
| Che Austin | Officer | Oct 19 '26 | Proposed Sale | 10.38 | 2,200 | 22,836 | Oct 19 10:08 AM | |
| Coen Steven P. | See remarks | Oct 05 '26 | Sale | 15.00 | 2,403 | 36,045 | 49,448 | Oct 07 05:00 PM |
| Coen Steven P. | Officer | Oct 05 '26 | Proposed Sale | 15.00 | 2,403 | 36,045 | Oct 05 02:04 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| IWN | iShares Russell 2000 Value ETF | AUM: 14.17B |
| THNQ | ROBO Global Artificial Intelligence ETF | AUM: 420.79M |
| IBB | iShares Biotechnology ETF | AUM: 11.39B |
| VTWO | Vanguard Russell 2000 Index ETF | AUM: 16.90B |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | AUM: 2.54B |
| SCHA | Schwab U.S. Small-Cap ETF | AUM: 22.44B |
| DFAS | U.S. Small Cap Portfolio-ETF Class Shares | AUM: 15.64B |
News
latest 14 of 198- Ginkgo Bioworks Misses On EPS, But A Revenue Beat, Narrowing Losses And A Novo Lab Sale Advance Its Autonomous-Lab Pivot (Earnings Whispers) -14.51% +13.35%
- Ginkgo Bioworks Must Show Revenue Has Bottomed As Loss Expected To Narrow Sharply (Earnings Whispers) -12.01%
- Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program (Business Wire) +14.64%
- Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop (PR Newswire)
- What Needs To Be True To Buy Twist Bioscience Stock Now? (Trefis)
- Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data (Business Wire)
- Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines (Business Wire)
- Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery (PR Newswire)
- The $59B Quiet Shift Reshaping How Patients Access Care (PR Newswire)
- Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab (PR Newswire) -13.47%
- Earnings To Watch: Ginkgo Bioworks Holdings Inc (DNA) Reports Q1 2026 Result (GuruFocus.com)
- Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation (PR Newswire) +12.80%
- Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen (Benzinga)
- Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure (PR Newswire)
Quarterly earnings
2026Q3 EPS -0.640 beat -0.678, from -1.450 a year earlier. Sales 27.71 beat 21.50, from 38.84 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-05 16:30 | -0.640 | -0.678 | -0.640 | 27.71 | 21.50 | EPS -5.6% · sales +28.9% | vs 2025Q3, year-ago quarter · EPS -55.9% · sales -28.6% | 2 EPS · 3 sales | Open +1.96% vs SPY +0.25%. Close +13.35% vs SPY +0.31% |
| 2026Q2ended 2026-06-30 | 2026-08-05 16:30 | -0.750 | -0.895 | -1.147 | 20.16 | 24.05 | EPS -16.2% · sales -16.2% | vs 2025Q2, year-ago quarter · EPS -31.8% · sales -59.4% | 2 | Open -2.56% vs SPY +0.05%. Close -9.28% vs SPY -0.16% |
| 2026Q1ended 2026-03-31 | 2026-05-07 16:30 | -1.390 | -1.211 | -1.387 | 19.47 | 42.93 | EPS +14.8% · sales -54.6% | vs 2025Q1, year-ago quarter · EPS -17.3% · sales -59.7% | 2 EPS · 3 sales | Open -16.18% vs SPY +0.46%. Close -13.47% vs SPY +0.83% |
| 2025Q4ended 2025-12-31 | 2026-02-26 16:30 | -1.410 | -1.455 | -1.456 | 33.00 | 37.09 | EPS -3.1% · sales -11.0% | vs 2024Q4, year-ago quarter · EPS -29.5% · sales -24.7% | 2 EPS · 3 sales | Open -17.55% vs SPY -0.90%. Close -30.48% vs SPY -0.48% |
| 2025Q3ended 2025-09-30 | 2025-11-06 16:30 | -1.450 | -1.241 | -1.452 | 38.84 | 38.95 | EPS +16.8% · sales -0.3% | vs 2024Q3, year-ago quarter · EPS +34.3% · sales -56.4% | 3 EPS · 4 sales | Open -8.94% vs SPY -0.36%. Close -20.80% vs SPY +0.10% |
| 2025Q2ended 2025-06-30 | 2025-08-07 16:30 | -1.100 | -1.567 | -1.099 | 49.60 | 41.60 | EPS -29.8% · sales +19.3% | vs 2024Q2, year-ago quarter · EPS -75.0% · sales -11.7% | 3 EPS · 4 sales | Open +4.38% vs SPY +0.29%. Close -8.69% vs SPY +0.78% |
| 2025Q1ended 2025-03-31 | 2025-05-06 16:30 | -1.680 | -1.534 | -1.677 | 48.32 | 38.80 | EPS +9.5% · sales +24.5% | vs 2024Q1, year-ago quarter · EPS -47.5% · sales +27.3% | 5 | Open +5.89% vs SPY +0.24%. Close +14.73% vs SPY +0.42% |
| 2024Q4ended 2024-12-31 | 2025-02-25 16:30 | -2.000 | -1.504 | -1.998 | 43.85 | 44.47 | EPS +33.0% · sales -1.4% | vs 2023Q4, year-ago quarter · EPS -54.5% · sales +26.2% | 5 | Open -14.29% vs SPY +0.28%. Close -11.47% vs SPY +0.05% |
| 2024Q3ended 2024-09-30 | 2024-11-12 16:30 | -1.080 | -2.728 | -1.080 | 89.05 | 44.99 | EPS -60.4% · sales +97.9% | vs 2023Q3, year-ago quarter · EPS -83.1% · sales +60.6% | 4 EPS · 5 sales | Open +8.34% vs SPY +0.08%. Close +2.50% vs SPY +0.05% |
| 2024Q2ended 2024-06-30 | 2024-08-08 16:30 | -4.400 | -3.098 | -4.231 | 56.21 | 43.14 | EPS +42.0% · sales +30.3% | vs 2023Q2, year-ago quarter · EPS +22.2% · sales -30.2% | 5 | Open +8.47% vs SPY -0.16%. Close -5.46% vs SPY +0.44% |
| 2024Q1ended 2024-03-31 | 2024-05-09 16:30 | -3.200 | -3.332 | -3.311 | 37.94 | 45.97 | EPS -4.0% · sales -17.5% | vs 2023Q1, year-ago quarter · EPS -27.3% · sales -53.0% | 6 | Open -13.37% vs SPY +0.32%. Close -17.29% vs SPY +0.13% |
| 2023Q4ended 2023-12-31 | 2024-02-29 16:30 | -4.400 | -3.868 | -4.282 | 34.76 | 42.50 | EPS +13.8% · sales -18.2% | vs 2022Q4, year-ago quarter · EPS +10.0% · sales -64.6% | 6 | Open -15.79% vs SPY +0.18%. Close -15.13% vs SPY +0.94% |
| 2023Q3ended 2023-09-30 | 2023-11-08 16:30 | -6.400 | -3.656 | -6.210 | 55.43 | 48.08 | EPS +75.1% · sales +15.3% | vs 2022Q3, year-ago quarter · EPS -61.0% · sales -16.5% | 7 EPS · 6 sales | - |
| 2023Q2ended 2023-06-30 | 2023-08-09 16:30 | -3.600 | -3.452 | -3.586 | 80.57 | 71.50 | EPS +4.3% · sales +12.7% | vs 2022Q2, year-ago quarter · EPS -78.0% · sales -44.3% | 8 EPS · 6 sales | - |
| 2023Q1ended 2023-03-31 | 2023-05-10 16:30 | -4.400 | -3.400 | -4.290 | 80.70 | 71.73 | EPS +29.4% · sales +12.5% | vs 2022Q1, year-ago quarter · EPS -70.3% · sales -52.1% | 8 EPS · 6 sales | - |
| 2022Q4ended 2022-12-31 | 2023-03-01 16:30 | -4.000 | -8.324 | -3.807 | 98.29 | 88.64 | EPS -51.9% · sales +10.9% | vs 2021Q4, year-ago quarter · EPS -90.9% · sales -33.8% | 7 EPS · 6 sales | - |
Annual earnings
2025FY EPS -5.640 matched -5.640, from -10.540 a year earlier. Sales 170.16 missed 173.86, from 227.04 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2029FYestimate | - | -2.240 | - | - | 369.1 | - |
| 2028FYestimate | - | -3.240 | - | - | 92.60 | - |
| 2027FYestimate | - | -4.025 | - | - | 96.90 | - |
| 2026FYestimate | - | -4.355 | - | - | 90.07 | - |
| 2025FY | -5.640 | -5.640 | -5.680 | 170.16 | 173.86 | - |
| 2024FY | -10.540 | -10.080 | -10.541 | 227.04 | 227.75 | - |
| 2023FY | -18.400 | -17.600 | -18.368 | 251.46 | 258.72 | - |
| 2022FY | -50.000 | -55.632 | -50.145 | 477.71 | 471.16 | - |
| 2021FY | -55.600 | -7.900 | -46.883 | 313.84 | 251.52 | - |
Quarterly results
2026Q3 revenue 27.71, from 38.84 a year earlier. Operating margin -157.63%, from -227.14% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY S 90.07 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | S | per share | 2026-11-10 | 90.07 | +3.0% |
| 2026Q4 | S | per share | 2026-11-10 | 24.30 | +0.8% |
| 2026FY | E | per share | 2026-11-06 | -4.36 | +11.4% |
| 2026Q4 | E | per share | 2026-11-06 | -1.04 | 0.0% |
| 2026Q4 | R | per share | 2026-11-06 | -0.82 | 0.0% |
| 2026Q3 | S | per share | 2026-10-26 | 21.50 | 0.0% |
| 2026Q3 | E | per share | 2026-10-12 | -0.68 | -32.7% |
| 2026FY | R | per share | 2026-09-30 | -3.81 | 0.0% |
| 2026Q3 | R | per share | 2026-09-30 | -0.86 | 0.0% |
| 2026Q2 | E | per share | 2026-08-06 | -1.09 | +21.8% |
| 2026Q2 | S | per share | 2026-08-06 | 21.95 | -8.7% |
| 2026Q2 | R | per share | 2026-05-08 | -1.32 | 0.0% |
| 2026Q1 | S | per share | 2026-03-22 | 42.93 | 0.0% |
| 2026Q1 | E | per share | 2026-03-14 | -1.21 | 0.0% |
| 2026Q1 | R | per share | 2026-03-14 | -1.34 | 0.0% |
| 2025FY | E | per share | 2026-01-21 | -5.64 | 0.0% |
| 2025Q4 | E | per share | 2026-01-21 | -1.46 | 0.0% |
| 2025FY | R | per share | 2026-01-21 | -5.94 | 0.0% |
| 2025Q4 | R | per share | 2026-01-21 | -1.80 | 0.0% |
| 2025Q4 | S | per share | 2026-01-21 | 37.09 | 0.0% |
| 2025FY | S | - | 2026-01-21 | 173.86 | 0.0% |
| 2025Q3 | E | per share | 2025-11-05 | -1.24 | 0.0% |
| 2025Q3 | R | per share | 2025-11-05 | -1.23 | 0.0% |
| 2025Q3 | S | per share | 2025-11-05 | 38.95 | 0.0% |
| 2025Q2 | E | per share | 2025-08-02 | -1.57 | 0.0% |
| 2025Q2 | R | per share | 2025-08-02 | -1.61 | 0.0% |
| 2025Q2 | S | per share | 2025-08-02 | 41.60 | 0.0% |
| 2025Q1 | E | per share | 2025-04-15 | -1.53 | -1.3% |
| 2025Q1 | S | per share | 2025-04-15 | 38.80 | -1.6% |
| 2025Q1 | R | per share | 2025-03-03 | -1.97 | +2.3% |
| 2024Q4 | E | per share | 2025-02-01 | -1.50 | 0.0% |
| 2024FY | S | - | 2025-02-01 | 227.75 | 0.0% |
| 2024FY | E | per share | 2025-01-27 | -10.08 | 0.0% |
| 2024FY | R | per share | 2025-01-27 | -10.02 | 0.0% |
| 2024Q4 | R | per share | 2025-01-27 | -1.53 | 0.0% |
| 2024Q4 | S | per share | 2025-01-27 | 44.47 | 0.0% |
| 2024Q3 | E | per share | 2024-11-04 | -2.73 | 0.0% |
| 2024Q3 | R | per share | 2024-11-04 | -2.70 | 0.0% |
| 2024Q3 | S | per share | 2024-10-26 | 44.99 | 0.0% |
| 2024Q2 | R | per share | 2024-07-28 | -0.08 | 0.0% |
| 2024Q2 | S | per share | 2024-07-28 | 43.14 | 0.0% |
| 2024Q2 | E | per share | 2024-06-25 | -0.08 | -0.8% |
| 2024Q1 | E | per share | 2024-04-11 | -0.08 | -0.7% |
| 2024Q1 | S | per share | 2024-04-08 | 45.97 | -0.8% |
| 2024Q1 | R | per share | 2024-03-06 | -0.09 | +12.5% |
| 2023FY | E | per share | 2024-01-27 | -0.44 | 0.0% |
| 2023FY | S | - | 2024-01-27 | 258.72 | 0.0% |
| 2023FY | R | per share | 2024-01-23 | -0.47 | 0.0% |
Estimate history
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|
| EPS per share | -3.93 | -46.883 | -50.145 | -18.368 | -10.541 | -5.64 | -4.6302 | - |
| Sales USD millions | 77 | 314 | 478 | 251 | 227 | 170 | 101 | - |
| Shares million shares | 32 | 40 | 42 | 47 | 51 | 55 | - | 61 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -1.08 | -1.998 | -1.677 | -1.099 | -1.452 | -1.456 | -1.387 | -1.147 | -0.641 |
| Sales USD millions | 89 | 44 | 48 | 50 | 39 | 33 | 19 | 20 | 28 |
| Shares million shares | 50 | 51 | 52 | 52 | 54 | 55 | 59 | 61 | 61 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 |
|---|---|---|---|---|---|---|---|
| Total Revenue | 100.74 | 170.16-25.1% | 227.04-9.7% | 251.46-47.4% | 477.71+52.2% | 313.84+309.4% | 76.66 |
| Cost of Goods Sold Incl. D&A | 60.04 | 87.26-2.6% | 89.57-17.7% | 108.81-59.1% | 265.85+83.9% | 144.59+390.5% | 29.48 |
| Gross Profit | 40.70 | 82.89-39.7% | 137.47-3.6% | 142.64-32.7% | 211.86+25.2% | 169.25+258.7% | 47.18 |
| Selling, General and Administrative Excl. Other | 284.76 | 397.00-33.6% | 597.77-26.6% | 814.87-65.7% | 2,373.78+18.9% | 1,997.11+984.1% | 184.21 |
| Research and Development | 141.09 | 203.48-43.4% | 359.25-31.7% | 525.81-50.0% | 1,052.64-7.2% | 1,134.76+610.2% | 159.77 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -244.06 | -314.11 | -460.30 | -672.23 | -2,161.92 | -1,827.87 | -137.03 |
| Interest Expense | - | - | 0.090.0% | 0.09-18.2% | 0.11-95.4% | 2.37-0.4% | 2.38 |
| Unusual Expense | 5.50 | 9.18-92.0% | 114.61-38.7% | 187.01 | -77.94 | -79.34 | -8.79 |
| Net Income Before Taxes | -255.98 | -313.60 | -547.51 | -892.94 | -2,121.40 | -1,838.12 | -124.83 |
| Income Taxes | -0.87 | -0.84 | -0.48 | -0.07 | -15.03 | -1.48-178.3% | 1.89 |
| Consolidated Net Income | -255.12 | -312.76 | -547.03 | -892.87 | -2,106.37 | -1,836.64 | -126.72 |
| Net Income From Continuing Operations | -255.12 | -312.76 | -547.03 | -892.87 | -2,104.93 | -1,830.05 | -126.61 |
| Net Income | -275.54 | -312.76 | -547.03 | -892.87 | -2,104.93 | -1,830.05 | -126.61 |
| EPS (Recurring) per share | -4.25 | -5.52 | -9.00 | -15.67 | -51.52 | -48.26 | -4.12 |
| EPS (Basic, Before Extraordinaries) per share | -4.63 | -5.64 | -10.54 | -18.37 | -50.15 | -45.43 | -3.93 |
| EPS (Diluted) per share | -4.63 | -5.64 | -10.54 | -18.37 | -50.15 | -46.88 | -3.93 |
| EBITDA | -193.25 | -255.12 | -397.28 | -600.68 | -2,100.29 | -1,798.79 | -123.16 |
| Non-Operating Income (Expense) | -6.42 | 9.69-64.8% | 27.50 | -33.61 | -37.31 | -87.22-1606.4% | 5.79 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 41.19 | 64.42-27.4% | 88.75-52.2% | 185.58-87.9% | 1,533.33+24.8% | 1,228.27+350834.3% | 0.35 |
| Price To Sales Ratio ratio | 8.15 | 2.71 | 2.24 | 13.07 | 5.94 | 42.67 | - |
| Gross Margin % | 40.40 | 48.72 | 60.55 | 56.73 | 44.35 | 53.93 | 61.55 |
| Operating Margin % | -242.27 | -184.60 | -202.74 | -267.34 | -452.56 | -582.43 | -178.75 |
| Net Margin % | -273.52 | -183.81 | -240.94 | -355.08 | -440.63 | -583.12 | -165.16 |
| Shares Outstanding million shares | 61.50 | 55.21+7.5% | 51.37+9.2% | 47.03+11.2% | 42.30+5.0% | 40.28+25.1% | 32.21 |
| Market Capitalization | 647.12 | 647.12+21.0% | 534.98-82.9% | 3,131.11+27.9% | 2,447.56-81.7% | 13,390.67+0.4% | 13,335.81 |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 27.71-28.7% | 20.16-59.4% | 19.47-59.7% | 33.40-23.8% | 38.84-56.4% | 49.60-11.8% | 48.32+27.4% | 43.85+26.2% |
| Cost of Goods Sold Incl. D&A | 13.84-48.7% | 14.03-54.2% | 15.90-42.0% | 16.26-21.0% | 26.97-7.5% | 30.61-1.4% | 27.41+24.2% | 20.57+29.0% |
| Gross Profit | 13.87+16.8% | 6.12-67.8% | 3.58-82.9% | 17.13-26.4% | 11.87-80.2% | 18.99-24.5% | 20.91+31.8% | 23.27+23.7% |
| Selling, General and Administrative Excl. Other | 57.55-42.5% | 63.56-27.3% | 74.95-29.8% | 88.70-29.0% | 100.08-10.3% | 87.40-50.3% | 106.82-38.8% | 124.90-27.9% |
| Research and Development | 28.91-47.6% | 33.90-9.8% | 37.12-33.2% | 41.16-37.1% | 55.19-7.8% | 37.58-67.9% | 55.56-55.0% | 65.42-39.3% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -43.68 | -57.44 | -71.37 | -71.57 | -88.22 | -68.41 | -85.92 | -101.63 |
| Interest Expense | - | - | - | - | - | - | - | 0.00-100.0% |
| Unusual Expense | 1.18 | -0.88 | 1.21-17.1% | 3.99-53.2% | -4.20-338.6% | -2.64-103.8% | 1.46-92.0% | 8.53-50.1% |
| Net Income Before Taxes | -41.26 | -57.19 | -76.14 | -81.39 | -80.75 | -60.58 | -90.87 | -107.86 |
| Income Taxes | -0.27 | 0.13 | -0.08-188.9% | -0.64 | 0.00 | -0.28-247.4% | 0.09+200.0% | -0.33 |
| Consolidated Net Income | -40.98 | -57.32 | -76.06 | -80.75 | -80.75 | -60.30 | -90.96 | -107.53 |
| Net Income From Continuing Operations | -40.98 | -57.32 | -76.06 | -80.75 | -80.75 | -60.30 | -90.96 | -107.53 |
| Net Income | -40.98 | -71.22 | -82.59 | -80.75 | -80.75 | -60.30 | -90.96 | -107.53 |
| EPS (Recurring) per share | -0.63 | -1.16 | -1.37 | -1.41 | -1.50 | -1.13 | -1.66 | -1.88 |
| EPS (Basic, Before Extraordinaries) per share | -0.64 | -1.15 | -1.39 | -1.46 | -1.45 | -1.10 | -1.68 | -2.00 |
| EPS (Diluted) per share | -0.64 | -1.15 | -1.39 | -1.46 | -1.45 | -1.10 | -1.68 | -2.00 |
| EBITDA | -31.64 | -45.13 | -58.58 | -57.90 | -74.05 | -52.62 | -70.55 | -85.97 |
| Non-Operating Income (Expense) | 3.60+10.1% | -0.63-112.1% | -3.55 | -5.84-355.0% | 3.27 | 5.19+90.8% | -3.49-131.2% | 2.29 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 6.06-57.0% | 6.00-65.9% | 12.52-22.4% | 16.61+2.3% | 14.09+28.7% | 17.58-40.1% | 16.14-49.9% | 16.24-52.8% |
| Price To Sales Ratio ratio | 8.15 | 5.50 | 2.58 | 2.71 | 4.49 | 2.67 | 1.30 | 2.33 |
| Gross Margin % | 50.04 | 30.37 | 18.37 | 51.30 | 30.56 | 38.28 | 43.27 | 53.08 |
| Operating Margin % | -157.62 | -284.99 | -366.51 | -214.30 | -227.14 | -137.92 | -177.81 | -231.77 |
| Net Margin % | -147.90 | -353.33 | -424.09 | -241.80 | -207.93 | -121.56 | -188.25 | -245.25 |
| Shares Outstanding million shares | 61.50+14.2% | 60.71+15.8% | 58.66+13.5% | 55.21+7.5% | 53.84+7.5% | 52.43+7.1% | 51.70+8.1% | 51.37+9.2% |
| Market Capitalization | 647.12-21.0% | 617.63-1.1% | 357.74+14.0% | 478.57-10.5% | 819.39+91.2% | 624.73-2.3% | 313.69-85.6% | 534.98-82.9% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 429.65-24.3% | 567.41-40.2% | 948.86-28.3% | 1,324.01-14.6% | 1,550.00+307.0% | 380.80 |
| Short Term Receivables | 24.25+8.1% | 22.44-29.3% | 31.74-62.2% | 84.03-43.9% | 149.90+501.3% | 24.93 |
| Inventories | 0.00 | 0.00-100.0% | 0.05-98.9% | 4.36+29.8% | 3.36+22.6% | 2.74 |
| Other Current Assets | 17.93+39.1% | 12.89-38.9% | 21.10-44.0% | 37.68+90.5% | 19.78+9.5% | 18.07 |
| Total Current Assets | 471.84-21.7% | 602.74-39.8% | 1,001.75-30.9% | 1,450.08-15.8% | 1,723.05+304.0% | 426.54 |
| Net Property, Plant & Equipment | 528.70-11.6% | 598.15+50.6% | 397.22-44.7% | 718.79+393.1% | 145.77+20.0% | 121.44 |
| Total Investments and Advances | 53.20-38.9% | 87.04-27.0% | 119.29-25.1% | 159.30+38.2% | 115.23+11.7% | 103.12 |
| Long-Term Note Receivable | 7.13-49.7% | 14.17+4.2% | 13.60-63.9% | 37.66 | 0.00-100.0% | 13.30 |
| Intangible Assets | 56.92-21.5% | 72.51-45.1% | 131.98-22.9% | 171.25+298.7% | 42.95+734.0% | 5.15 |
| Other Assets | 1.90-32.9% | 2.83+88.7% | 1.50-33.0% | 2.24-94.9% | 43.99+685.5% | 5.60 |
| Total Assets | 1,119.70-18.7% | 1,377.45-17.3% | 1,665.34-34.4% | 2,539.32+22.6% | 2,070.99+206.7% | 675.15 |
| Short Term Debt Incl. Current Port. of LT Debt | 22.81-21.2% | 28.96+45.3% | 19.93-32.0% | 29.33+3810.7% | 0.75+56.3% | 0.48 |
| Accounts Payable | 10.57-25.4% | 14.17+52.0% | 9.32-10.8% | 10.45+27.6% | 8.19-41.0% | 13.89 |
| Other Current Liabilities | 62.60-2.4% | 64.13-52.4% | 134.60+1.1% | 133.18+5.8% | 125.83+113.9% | 58.84 |
| Total Current Liabilities | 95.97-10.5% | 107.27-34.5% | 163.86-5.3% | 172.96+28.3% | 134.76+84.0% | 73.22 |
| Long Term Debt | 417.08-4.9% | 438.77+97.8% | 221.84-46.3% | 413.26+1754.8% | 22.28+34.9% | 16.52 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 98.06-15.0% | 115.36-36.8% | 182.50-15.8% | 216.83-37.4% | 346.57+200.4% | 115.36 |
| Total Liabilities | 611.11-7.6% | 661.39+16.4% | 568.19-29.2% | 803.04+59.5% | 503.61+145.5% | 205.10 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 508.59-29.0% | 716.06-34.7% | 1,097.15-36.8% | 1,736.28+15.3% | 1,505.37+226.3% | 461.38 |
| Total Shareholders Equity | 508.59-29.0% | 716.06-34.7% | 1,097.15-36.8% | 1,736.28+15.3% | 1,505.37+226.3% | 461.38 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 62.01+614.4% | 8.68 |
| Total Equity | 508.59-29.0% | 716.06-34.7% | 1,097.15-36.8% | 1,736.28+10.8% | 1,567.38+233.4% | 470.05 |
| Total Liabilities & Stockholders Equity | 1,119.70-18.7% | 1,377.45-17.3% | 1,665.34-34.4% | 2,539.32+22.6% | 2,070.99+206.7% | 675.15 |
| Book Value Per Share per share | 9.21-33.9% | 13.94-40.2% | 23.33-43.2% | 41.05+9.8% | 37.37+161.0% | 14.32 |
| Tangible Book Value Per Share per share | 8.18-34.7% | 12.53-38.9% | 20.52-44.5% | 37.00+1.9% | 36.30+156.4% | 14.16 |
| Full-Time Employees people | 485-41.8% | 834-31.5% | 1,218-5.7% | 1,292+101.6% | 641+31950.0% | 2 |
| Price to Book Ratio ratio | 1.60 | 0.62 | 2.50 | 1.71 | 8.90 | 8.60 |
| Return on Assets % | -25.05 | -35.96 | -42.47 | -91.31 | -176.62 | - |
| Return on Equity % | -51.08 | -60.34 | -63.02 | -129.87 | -243.13 | - |
| Return on Invested Capital % | -33.79 | -47.37 | -67.69 | -97.92 | -119.80 | -26.49 |
| Quick Ratio ratio | 4.92 | 5.62 | 6.11 | 8.36 | 12.76 | 5.79 |
| Current Ratio ratio | 4.92 | 5.62 | 6.11 | 8.38 | 12.79 | 5.83 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 |
|---|---|---|---|---|---|---|---|
| Net Income | -255.12 | -312.76 | -547.03 | -892.87 | -2,103.49 | -1,836.64 | -126.72 |
| Depreciation | 50.81 | 58.99-6.4% | 63.02-11.9% | 71.55+16.1% | 61.63+111.9% | 29.08+109.8% | 13.86 |
| Other Funds (Non Cash) | 104.53 | 128.17-49.7% | 255.03-48.7% | 496.78-73.0% | 1,841.27+14.0% | 1,615.29+45529.7% | 3.54 |
| Funds from Operations | -101.13 | -126.97 | -229.91 | -325.34 | -215.19 | -192.28 | -109.31 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -65.86 | -44.09 | -89.67-400.5% | 29.84 | -37.01 | -61.54 | -26.52 |
| Cash from Operating Activities | -166.99 | -171.06 | -319.58 | -295.50 | -252.20 | -253.82 | -135.83 |
| Capital Expenditures | -6.56 | -7.67 | -62.54 | -40.80 | -52.27 | -56.52 | -57.82 |
| Net Assets From Acquisitions | - | 0.00 | 0.00 | -42.98 | -63.36 | -12.04 | 0.00 |
| Sale of Fixed Assets and Businesses | - | 0.57 | -4.75-207.2% | 4.43-94.6% | 82.37+37.4% | 59.93 | 0.00 |
| Purchase or Sale of Investments | 111.15 | -233.25-5260.4% | 4.52 | 0.00 | -3.69 | -5.00 | 0.00 |
| Purchase of Investments | -233.59 | -418.63 | 0.00 | 0.00 | -3.69 | -5.00 | 0.00 |
| Sale Or Maturity of Investments | 344.74 | 185.38+4001.3% | 4.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | -1.34 | -40.44 | 0.00 | -10.10 |
| Other Sources | 0.05 | 0.05-90.7% | 0.54 | 0.00-100.0% | 10.00+3233.3% | 0.30-62.5% | 0.80 |
| Cash from Investing Activities | 105.22 | -240.29 | -62.24 | -80.69 | -67.39 | -13.32 | -67.12 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 31.16 | 18.13+22562.5% | 0.08 | -0.49-100.5% | 98.08-93.4% | 1,484.80+1530.4% | 91.07 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -25.00 | 0.00 |
| Sale of Common Pref Stock | 31.16 | 18.13+22562.5% | 0.08 | -0.49-100.5% | 98.08-93.5% | 1,509.80+1557.8% | 91.07 |
| Proceedsfrom Stock Options | 31.16 | 18.13 | -0.00 | -0.58-100.6% | 97.84-93.5% | 1,509.63+1558.2% | 91.04 |
| Issuance or Reduction of Debt, Net | -0.04 | -0.35 | -0.90 | -1.29 | -1.24 | -1.12 | -0.75 |
| Change in Long Term Debt | -0.04 | -0.35 | -0.90 | -1.29 | -1.24 | -1.12 | -0.75 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -0.04 | -0.35 | -0.90 | -1.29 | -1.24 | -1.12 | -0.75 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | -0.92 | -1.43 | -1.50 | -9.46 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | -0.92 | -1.43 | -1.50 | -9.46 | 0.00 |
| Cash from Financing Activities | 31.12 | 17.77 | -1.74 | -3.22-103.4% | 95.34-93.5% | 1,474.21+1532.2% | 90.32 |
| Exchange Rate Effect | -0.23 | 0.20 | -0.28 | -0.59-164.8% | 0.91 | -0.02 | 0.00 |
| Net Change in Cash | -30.88 | -393.37 | -383.84 | -380.00 | -223.35-118.5% | 1,207.05 | -112.63 |
| Free Cash Flow | -173.54 | -178.72 | -382.13 | -336.30 | -304.47 | -310.34 | -193.65 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | -1.36 | -0.94 | -0.80 | -14.61 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 287.22-39.0% | 305.08-37.1% | 380.34-27.5% | 429.65-24.3% | 470.67-24.0% | 484.64-33.9% | 524.87-37.8% | 567.41-40.2% |
| Short Term Receivables | 11.48-48.7% | 13.01-43.8% | 20.27-25.4% | 24.25+8.1% | 22.36-8.6% | 23.13+22.4% | 27.17+10.6% | 22.44-29.3% |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% |
| Other Current Assets | 12.13-7.1% | 14.44-5.4% | 9.35-25.2% | 17.93+39.1% | 13.06-31.1% | 15.26-51.9% | 12.50-64.0% | 12.89-38.9% |
| Total Current Assets | 310.84-38.6% | 332.54-36.4% | 409.95-27.4% | 471.84-21.7% | 506.08-23.6% | 523.02-33.2% | 564.53-37.5% | 602.74-39.8% |
| Net Property, Plant & Equipment | 493.84-9.4% | 504.85-10.2% | 516.82-11.1% | 528.70-11.6% | 544.79-11.7% | 562.15-10.6% | 581.22+39.5% | 598.15+50.6% |
| Total Investments and Advances | 98.79+46.9% | 106.95+53.9% | 52.62-21.7% | 53.20-38.9% | 67.27-35.7% | 69.50-34.1% | 67.22-43.7% | 87.04-27.0% |
| Intangible Assets | 39.73-35.4% | 44.39-32.9% | 48.86-28.9% | 56.92-21.5% | 61.52-22.7% | 66.15-27.0% | 68.76-45.1% | 72.51-45.1% |
| Other Assets | 1.25-47.5% | 1.32-50.0% | 4.81+70.0% | 1.90-32.9% | 2.38-12.2% | 2.64+9.1% | 2.83+4.4% | 2.83+88.7% |
| Total Assets | 944.45-20.6% | 990.05-19.6% | 1,033.08-20.1% | 1,119.70-18.7% | 1,189.16-19.7% | 1,231.01-24.3% | 1,293.46-18.2% | 1,377.45-17.3% |
| Short Term Debt Incl. Current Port. of LT Debt | 0.00 | 0.00 | 0.00 | 22.81-21.2% | 0.00 | 0.00 | 0.00 | 28.96+45.3% |
| Accounts Payable | 7.18-32.9% | 9.57-14.6% | 16.31+44.7% | 10.57-25.4% | 10.70-31.8% | 11.20-51.4% | 11.27-58.3% | 14.17+52.0% |
| Other Current Liabilities | 58.67-43.9% | 63.16-26.1% | 63.29-39.4% | 62.60-2.4% | 104.58+5.9% | 85.52-40.2% | 104.40-26.5% | 64.13-52.4% |
| Total Current Liabilities | 65.85-42.9% | 72.74-24.8% | 79.59-31.2% | 95.97-10.5% | 115.28+0.7% | 96.72-41.8% | 115.67-31.6% | 107.27-34.5% |
| Long Term Debt | 397.20-6.1% | 404.11-5.8% | 410.70-5.5% | 417.08-4.9% | 422.87-5.1% | 428.83-5.2% | 434.56+85.3% | 438.77+97.8% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 88.77-2.7% | 92.91+0.4% | 99.63+4.0% | 98.06-15.0% | 91.23-25.8% | 92.51-46.8% | 95.81-49.8% | 115.36-36.8% |
| Total Liabilities | 551.82-12.3% | 569.76-7.8% | 589.92-8.7% | 611.11-7.6% | 629.38-7.8% | 618.06-22.0% | 646.04+8.7% | 661.39+16.4% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 392.64-29.9% | 420.28-31.4% | 443.15-31.6% | 508.59-29.0% | 559.78-29.8% | 612.95-26.4% | 647.43-34.4% | 716.06-34.7% |
| Total Shareholders Equity | 392.64-29.9% | 420.28-31.4% | 443.15-31.6% | 508.59-29.0% | 559.78-29.8% | 612.95-26.4% | 647.43-34.4% | 716.06-34.7% |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 392.64-29.9% | 420.28-31.4% | 443.15-31.6% | 508.59-29.0% | 559.78-29.8% | 612.95-26.4% | 647.43-34.4% | 716.06-34.7% |
| Total Liabilities & Stockholders Equity | 944.45-20.6% | 990.05-19.6% | 1,033.08-20.1% | 1,119.70-18.7% | 1,189.16-19.7% | 1,231.01-24.3% | 1,293.46-18.2% | 1,377.45-17.3% |
| Book Value Per Share per share | 6.38-38.7% | 6.92-40.8% | 7.55-39.7% | 9.21-33.9% | 10.40-34.7% | 11.69-31.3% | 12.52-39.3% | 13.94-40.2% |
| Tangible Book Value Per Share per share | 5.74-38.0% | 6.19-40.7% | 6.72-39.9% | 8.18-34.7% | 9.26-35.4% | 10.43-31.2% | 11.19-37.9% | 12.53-38.9% |
| Full-Time Employees people | - | - | - | 485-41.8% | - | - | - | 834-31.5% |
| Price to Book Ratio ratio | 1.60 | 1.31 | 0.67 | 0.80 | 1.25 | 0.90 | 0.41 | 0.62 |
| Return on Assets % | -23.91 | -26.55 | -25.61 | -25.05 | -25.43 | -22.07 | -32.84 | -35.96 |
| Return on Equity % | -53.57 | -57.08 | -54.63 | -51.08 | -50.02 | -43.59 | -57.76 | -60.34 |
| Return on Invested Capital % | -5.19 | -8.64 | -9.67 | -8.72 | -8.22 | -5.79 | -8.41 | -9.31 |
| Quick Ratio ratio | 4.72 | 4.57 | 5.15 | 4.92 | 4.39 | 5.41 | 4.88 | 5.62 |
| Current Ratio ratio | 4.72 | 4.57 | 5.15 | 4.92 | 4.39 | 5.41 | 4.88 | 5.62 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -40.98 | -57.32 | -76.06 | -80.75 | -80.75 | -60.30 | -90.96 | -107.53 |
| Depreciation | 12.04-15.0% | 12.31-22.0% | 12.80-16.7% | 13.66-12.7% | 14.17-17.5% | 15.79-8.9% | 15.37+19.4% | 15.65 |
| Other Funds (Non Cash) | 15.54-26.7% | 13.88-48.5% | 30.75-13.7% | 44.36-8.0% | 21.20-37.2% | 26.97-75.4% | 35.63-43.9% | 48.20-60.9% |
| Funds from Operations | -13.40 | -31.13 | -32.51 | -24.09 | -45.38 | -17.54 | -39.96 | -44.61 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -14.94-208.4% | -13.15 | -14.18 | -23.59-1182.1% | 13.78 | -22.71-486.2% | -11.56-3829.0% | 2.18-94.8% |
| Cash from Operating Activities | -28.35 | -44.27 | -46.69 | -47.68 | -31.61 | -40.25 | -51.52 | -42.44 |
| Capital Expenditures | -2.00 | -2.62 | -1.93 | -0.01 | 0.00 | -0.04 | -7.62 | -13.71 |
| Net Assets From Acquisitions | 0.00 | - | - | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 5.40 |
| Sale of Fixed Assets and Businesses | 0.00 | - | - | 0.57 | 0.00-100.0% | 0.00-100.0% | 0.00 | -5.34-473.4% |
| Purchase or Sale of Investments | -22.57 | 13.71 | 25.02 | 94.99+16564.9% | -73.06-1949.6% | -63.99 | -191.18 | 0.57 |
| Purchase of Investments | -89.36 | -44.28 | -83.16 | -16.79 | -81.71 | -128.95 | -191.18 | 0.00 |
| Sale Or Maturity of Investments | 66.79+673.0% | 57.99-10.7% | 108.18 | 111.78+19510.5% | 8.64+118.7% | 64.96 | 0.00 | 0.57 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.46+84.0% | 0.00-100.0% | 0.05-58.3% | -0.46 | 0.25-53.7% | 0.14 | 0.12 | 0.00 |
| Cash from Investing Activities | -24.10 | 11.09 | 23.13 | 95.10 | -72.82 | -63.89 | -198.68 | -13.09 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 6.50-34.7% | 16.49 | 0.00 | 8.17 | 9.96 | 0.00-100.0% | 0.00-100.0% | -0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 6.50-34.7% | 16.49 | 0.00 | 8.17 | 9.96 | 0.00-100.0% | 0.00-100.0% | -0.00 |
| Proceedsfrom Stock Options | 6.50-34.7% | 16.49 | 0.00 | 8.17 | 9.96 | 0.00 | 0.00 | -0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | -0.02 | -0.03 | -0.02 | -0.10 | -0.21 | -0.20 |
| Change in Long Term Debt | 0.00 | 0.00 | -0.02 | -0.03 | -0.02 | -0.10 | -0.21 | -0.20 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | -0.02 | -0.03 | -0.02 | -0.10 | -0.21 | -0.20 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% |
| Cash from Financing Activities | 6.50-34.6% | 16.49 | -0.02 | 8.14 | 9.94 | -0.10 | -0.21 | -0.20 |
| Exchange Rate Effect | 0.01-88.9% | 0.04-78.9% | -0.13-285.7% | -0.15 | 0.09 | 0.19 | 0.07 | -0.07-170.0% |
| Net Change in Cash | -45.94 | -16.65 | -23.70 | 55.41 | -94.39 | -104.05 | -250.34 | -55.80 |
| Free Cash Flow | -30.35 | -46.89 | -48.62 | -47.68 | -31.61 | -40.29 | -59.14 | -56.15 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| United States | 227.04 | 170.16 | -25.1% | 100.0% |
| Total | 227.04 | 170.16 | -25.1% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Biosecurity | 53.07 | 37.41 | -29.5% | 22.0% |
| Cell Engineering | 173.97 | 132.75 | -23.7% | 78.0% |
| Total | 227.04 | 170.16 | -25.1% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 19.32% | 9.5M | 49.1M | 2.20M |
| 2026-10-15 | 16.89% | 8.3M | 49.1M | 1.92M |
| 2026-09-30 | 14.90% | 7.3M | 49.1M | 1.36M |
| 2026-09-15 | 14.60% | 7.2M | 49.1M | 1.11M |
| 2026-08-31 | 14.06% | 6.9M | 48.8M | 1.19M |
| 2026-08-14 | 11.46% | 5.6M | 48.8M | 1.14M |
| 2026-07-31 | 10.89% | 5.3M | 48.8M | 1.20M |
| 2026-07-15 | 11.07% | 5.2M | 47.0M | 1.26M |
| 2026-06-30 | 10.97% | 5.2M | 47.0M | 1.25M |
| 2026-06-15 | 10.43% | 4.9M | 47.0M | 1.24M |
| 2026-05-29 | 9.79% | 4.6M | 46.6M | 1.22M |
| 2026-05-15 | 9.72% | 4.5M | 46.6M | 1.24M |
| 2026-04-30 | 12.01% | 5.2M | 43.6M | 1.21M |
| 2026-04-15 | 13.99% | 6.1M | 43.6M | 1.17M |
| 2026-03-31 | 14.03% | 6.1M | 43.8M | 1.15M |
| 2026-03-13 | 18.27% | 8.0M | 43.8M | 1.11M |
| 2026-02-27 | 17.08% | 7.5M | 43.8M | 1.04M |
| 2026-02-13 | 17.05% | 7.3M | 42.6M | 1.03M |
| 2026-01-30 | 15.73% | 6.7M | 42.6M | 1.03M |
| 2026-01-15 | 16.51% | 7.0M | 42.6M | 1.10M |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 1.00 | 8.60 | 9.80 | 9.20 | 1902.6% | 5.00 | 0.00 | 0.993 | -0.017 | 0.000 |
| call | 2.00 | 7.60 | 8.60 | 8.12 | 1006.5% | 4.00 | 0.00 | 0.978 | -0.039 | 0.001 |
| call | 3.00 | 6.60 | 7.60 | 11.98 | 751.3% | 0.00 | 0.00 | 0.969 | -0.039 | 0.001 |
| call | 4.00 | 5.60 | 6.60 | 5.47 | 595.3% | 0.00 | 0.00 | 0.959 | -0.039 | 0.001 |
| call | 5.00 | 4.60 | 5.60 | 0.00 | 474.3% | 0.00 | 0.00 | 0.947 | -0.038 | 0.002 |
| call | 6.00 | 3.70 | 4.60 | 4.00 | 376.9% | 14.00 | 0.00 | 0.932 | -0.036 | 0.002 |
| call | 7.00 | 2.70 | 3.60 | 6.45 | 294.1% | 9.00 | 0.00 | 0.912 | -0.034 | 0.002 |
| call | 8.00 | 2.05 | 2.60 | 2.30 | 218.4% | 184 | 2.00 | 0.883 | -0.030 | 0.003 |
| call | 9.00 | 1.15 | 1.80 | 1.25 | 191.2% | 56.00 | 10.00 | 0.786 | -0.036 | 0.004 |
| call | 10.00 | 0.60 | 0.95 | 0.80 | 140.9% | 246 | 58.00 | 0.584 | -0.056 | 0.006 |
| call | 11.00 | 0.25 | 0.45 | 0.45 | 124.6% | 1,070 | 77.00 | 0.398 | -0.051 | 0.006 |
| call | 12.00 | 0.15 | 0.25 | 0.25 | 132.6% | 616 | 0.00 | 0.236 | -0.039 | 0.005 |
| call | 13.00 | 0.00 | 0.15 | 0.10 | 142.3% | 631 | 27.00 | 0.149 | -0.032 | 0.003 |
| call | 14.00 | 0.00 | 0.10 | 0.15 | 153.8% | 630 | 0.00 | 0.100 | -0.026 | 0.003 |
| call | 15.00 | 0.00 | 0.05 | 0.05 | 153.3% | 697 | 4.00 | 0.056 | -0.017 | 0.002 |
| call | 16.00 | 0.00 | 0.15 | 0.20 | 172.6% | 156 | 0.00 | 0.051 | -0.017 | 0.002 |
| call | 17.00 | 0.00 | 0.15 | 0.05 | 190.8% | 1,583 | 0.00 | 0.047 | -0.018 | 0.001 |
| call | 18.00 | 0.00 | 0.35 | 0.05 | 207.4% | 520 | 0.00 | 0.044 | -0.018 | 0.001 |
| call | 19.00 | 0.00 | 0.10 | 0.10 | 260.4% | 56.00 | 0.00 | 0.068 | -0.031 | 0.002 |
| call | 20.00 | 0.00 | 0.60 | 0.22 | 237.0% | 259 | 0.00 | 0.039 | -0.019 | 0.001 |
| call | 21.00 | 0.00 | 0.60 | 0.20 | 250.1% | 42.00 | 0.00 | 0.038 | -0.020 | 0.001 |
| call | 22.00 | 0.00 | 0.15 | 0.10 | 263.1% | 77.00 | 0.00 | 0.036 | -0.020 | 0.001 |
| call | 23.00 | 0.00 | 0.15 | 0.20 | 275.0% | 114 | 0.00 | 0.035 | -0.020 | 0.001 |
| call | 24.00 | 0.00 | 0.15 | 0.10 | 286.2% | 51.00 | 0.00 | 0.034 | -0.021 | 0.001 |
| call | 25.00 | 0.00 | 0.60 | 0.00 | 296.6% | 0.00 | 0.00 | 0.033 | -0.021 | 0.001 |
| call | 26.00 | 0.00 | 0.65 | 0.00 | 306.8% | 0.00 | 0.00 | 0.032 | -0.021 | 0.001 |
| call | 27.00 | 0.00 | 0.60 | 0.00 | 316.6% | 0.00 | 0.00 | 0.032 | -0.021 | 0.001 |
| call | 28.00 | 0.00 | 0.60 | 0.00 | 325.8% | 0.00 | 0.00 | 0.031 | -0.022 | 0.001 |
| call | 29.00 | 0.00 | 0.60 | 0.00 | 334.7% | 0.00 | 0.00 | 0.030 | -0.022 | 0.001 |
| call | 30.00 | 0.00 | 0.10 | 0.11 | 396.7% | 1.00 | 0.00 | 0.051 | -0.037 | 0.002 |
| put | 1.00 | 0.00 | 0.05 | 0.00 | 831.7% | 0.00 | 0.00 | -0.007 | -0.015 | 0.000 |
| put | 2.00 | 0.00 | 0.60 | 0.00 | 769.8% | 0.00 | 0.00 | -0.022 | -0.039 | 0.001 |
| put | 3.00 | 0.00 | 0.60 | 0.00 | 583.4% | 0.00 | 0.00 | -0.031 | -0.039 | 0.001 |
| put | 4.00 | 0.00 | 0.60 | 0.00 | 457.3% | 0.00 | 0.00 | -0.041 | -0.038 | 0.001 |
| put | 5.00 | 0.00 | 0.60 | 0.00 | 361.5% | 0.00 | 0.00 | -0.053 | -0.037 | 0.002 |
| put | 6.00 | 0.00 | 0.60 | 0.00 | 283.5% | 0.00 | 0.00 | -0.068 | -0.035 | 0.002 |
| put | 7.00 | 0.00 | 0.15 | 0.04 | 216.7% | 20.00 | 1.00 | -0.087 | -0.033 | 0.002 |
| put | 8.00 | 0.00 | 0.15 | 0.10 | 157.0% | 27.00 | 10.00 | -0.117 | -0.029 | 0.003 |
| put | 9.00 | 0.15 | 0.25 | 0.15 | 125.3% | 118 | 84.00 | -0.214 | -0.035 | 0.004 |
| put | 10.00 | 0.40 | 0.80 | 0.45 | 155.1% | 394 | 6.00 | -0.414 | -0.055 | 0.006 |
| put | 11.00 | 0.75 | 1.75 | 0.72 | 216.4% | 86.00 | 0.00 | -0.602 | -0.050 | 0.006 |
| put | 12.00 | 1.65 | 2.50 | 2.30 | 225.4% | 262 | 1.00 | -0.764 | -0.038 | 0.005 |
| put | 13.00 | 2.55 | 3.50 | 2.17 | 266.0% | 54.00 | 0.00 | -0.851 | -0.030 | 0.003 |
| put | 14.00 | 3.50 | 4.40 | 3.60 | 284.0% | 25.00 | 4.00 | -0.900 | -0.024 | 0.003 |
| put | 15.00 | 4.50 | 5.40 | 3.00 | 313.4% | 6.00 | 0.00 | -0.944 | -0.015 | 0.002 |
| put | 16.00 | 5.50 | 6.30 | 4.80 | 319.7% | 2.00 | 0.00 | -0.949 | -0.015 | 0.002 |
| put | 17.00 | 6.40 | 7.30 | 2.95 | 344.2% | 1.00 | 0.00 | -0.953 | -0.016 | 0.001 |
| put | 18.00 | 7.40 | 8.30 | 0.00 | 366.5% | 0.00 | 0.00 | -0.956 | -0.016 | 0.001 |
| put | 19.00 | 8.50 | 9.30 | 0.00 | 389.0% | 0.00 | 0.00 | -0.959 | -0.017 | 0.001 |
| put | 20.00 | 9.50 | 10.40 | 7.60 | 429.1% | 0.00 | 0.00 | -0.961 | -0.017 | 0.001 |
| put | 21.00 | 10.40 | 11.40 | 0.00 | 449.0% | 0.00 | 0.00 | -0.962 | -0.017 | 0.001 |
| put | 22.00 | 11.50 | 12.30 | 9.70 | 442.6% | 0.00 | 0.00 | -0.964 | -0.018 | 0.001 |
| put | 23.00 | 12.50 | 13.40 | 0.00 | 482.0% | 0.00 | 0.00 | -0.965 | -0.018 | 0.001 |
| put | 24.00 | 13.30 | 14.40 | 0.00 | 495.2% | 0.00 | 0.00 | -0.966 | -0.018 | 0.001 |
| put | 25.00 | 14.40 | 15.30 | 0.00 | 487.2% | 0.00 | 0.00 | -0.967 | -0.018 | 0.001 |
| put | 26.00 | 15.40 | 16.40 | 0.00 | 523.0% | 0.00 | 0.00 | -0.968 | -0.018 | 0.001 |
| put | 27.00 | 16.40 | 17.30 | 0.00 | 513.2% | 0.00 | 0.00 | -0.968 | -0.018 | 0.001 |
| put | 28.00 | 17.40 | 18.30 | 0.00 | 525.3% | 0.00 | 0.00 | -0.969 | -0.019 | 0.001 |
| put | 29.00 | 18.40 | 19.30 | 0.00 | 534.7% | 0.00 | 0.00 | -0.970 | -0.019 | 0.001 |
| put | 30.00 | 19.40 | 20.30 | 0.00 | 547.9% | 0.00 | 0.00 | -0.970 | -0.019 | 0.001 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-09 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-05 | 8-K | Current report | 2026-11-05 | SEC |
| 2026-10-29 | 8-K | Current report | 2026-10-29 | SEC |
| 2026-10-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-16 | SEC |
| 2026-10-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-16 | SEC |
| 2026-10-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-16 | SEC |
| 2026-10-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-16 | SEC |
| 2026-10-19 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-19 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-19 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-19 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-19 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-19 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-07 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-05 | SEC |
| 2026-10-05 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-17 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-16 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-15 | SEC |
| 2026-09-15 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-25 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-21 | SEC |
| 2026-08-24 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-17 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-06 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-05 | 8-K | Current report | 2026-08-05 | SEC |
| 2026-07-30 | SCHEDULE 13G/A | SEC | ||
| 2026-07-30 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-28 | SEC |
| 2026-07-30 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-28 | SEC |
| 2026-07-30 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-28 | SEC |
| 2026-07-30 | 8-K | Current report | 2026-07-30 | SEC |
| 2026-07-20 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-16 | SEC |
| 2026-07-17 | 144 | Filing for proposed sale of securities under Rule 144. | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 1.34M | 7 |
| 2026-09 | 0 | 0 | 35.41K | 1 |
| 2026-08 | 0 | 0 | 2.30K | 1 |
| 2026-07 | 0 | 0 | 5.94K | 1 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 2.56K | 1 |
| 2026-04 | 0 | 0 | 3.54M | 10 |
| 2026-03 | 0 | 0 | 4.77K | 1 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 8.67K | 1 |
| 2025-12 | 0 | 0 | 6.54K | 1 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 6.87% |
| VIKING GLOBAL INVESTORS LP | 5.74% |
| Erste Asset Management GmbH | 3.94% |
| BAILLIE GIFFORD & CO | 3.72% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.35% |
| Anchorage Capital Group, L.L.C. | 2.80% |
| Legal & General Group Plc | 2.68% |
| STATE STREET CORP | 2.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 1.99% |
| FORBES J M & CO LLP | 1.52% |
Funds
| Fund | % owned |
|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.39% |
| iShares Russell 2000 ETF | 2.01% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.88% |
| Fidelity Small Cap Index Fund | 0.84% |
| PIMCO RAE US Small Fund | 0.81% |
| iShares Russell 2000 Value ETF | 0.72% |
| iShares Biotechnology ETF | 0.57% |
| ROBO Global Artificial Intelligence ETF | 0.57% |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF | 0.52% |
| VANGUARD RUSSELL 2000 INDEX FUND | 0.42% |
OakChart. DNA. Cached 15 minutes. Terms